Yorkville Advisors β Full Portfolio
14 tracked investments Β· listed companies and verified rows first
Abpro develops multispecific antibody therapeutics using proprietary discovery and engineering platforms, with lead programs targeting immuno-oncology, ophthalmology, and infectious disease; its advanced TetraBi antibody candidates ABP-102 (a T-cell engager for HER2+ solid tumors in partnership with Celltrion) and ABP-201 (targeting vascular disease in the eye through a territorial partnership with Abpro Bio) are designed to provide improved efficacy and safety profiles compared to existing treatments.
BiotechWoburn, US
Eugene Chan(Director)Ian Chan(Executive Officer, Director)Kevin Comerford(Executive Officer)Miles Suk(Chief Executive Officer and Chairman of the Board)Robert Markelewicz(Chief Medical Officer)in
BoardBenjamin Ha(Director)
Aptevo Therapeutics is a clinical-stage biotechnology company developing bispecific and trispecific immunotherapies to treat cancer.
BiotechHealthtechSeattle, US
Marvin L. White(Executive Officer, Director)inDaphne Taylor(Executive Officer)Jeffrey G. Lamothe(Executive Vice President and Chief Operating Officer)
BoardJohn E Niederhuber(Director)Daniel J Abdun-Nabi(Director)Grady Grant III(Director)
Co-investorsHEALTHCARE ROYALTY PARTNERS
CytoDyn is a biopharmaceutical company conducting clinical trials, including a Phase 2 colorectal cancer trial.
BiotechDigital HealthHealthtechMedical DevicesVancouver, US
Robert E. Hoffman(Executive Officer)inJacob P. Lalezari(Executive Officer)Tyler Blok(Executive Officer)inRyan M. Dunlap(Director)Michael D. Mulholland(Executive Officer)inNadar Z. Pourhassan(Executive Officer, Director)
Evolution Metals & Technologies is a US-controlled manufacturer of certified rare earth magnets, producing bonded and sintered magnets at commercial scale in South Korea using NdPr metal sourced from outside China.
Advanced ManufacturingHardwareNew MaterialsMiami, US
Christopher Clower(Executive Officer)inSuk Jin Moon(Executive Officer)David Wilcox(Executive Officer, Director)John Arrastia(Executive Officer)Andrew F. Knaggs(Executive Officer)inFrank Moon(Chief Executive Officer)
Nakamoto Inc. operates a portfolio of Bitcoin-native companies, holding Bitcoin as a treasury asset and making minority investments in digital-asset businesses, while also operating a patient-focused healthcare practice that provides evidence-based medical services including pain management, addiction treatment, and telemedicine options.
HealthtechSalt Lake City, US
Tim Pickett(Chief Medical Officer and Director)inJared Barrera(Executive Officer)inAdam Cox(Executive Officer, Director)inDavid Bailey(Chief Executive Officer, Chairman)inTeresa Gendron(Chief Financial Officer)Amanda Fabiano(Chief Operating Officer)
Co-investorsACTAI VenturesArrington CapitalOff the Chain Capital
Nomadar is a sports company that combines athletics with technology and artificial intelligence, offering events, products, and services including a High Performance Training Program and a multipurpose technology center.
AI & Machine LearningEdTechSports TechMarshall, US
Rafael Contreras(Executive Officer, Director)Carlos Lacave(Executive Officer)inJoaquin Martin(Executive Officer)inIvan Contreras(Executive Officer)
BoardPeter Moore(Director)Manuel Vizcaino(Director)
NW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy.
BiotechHealthtechBethesda, US
Alton L. Boynton(Co-founder & Chief Scientific Officer)Marnix Bosch(Executive Officer)inLeslie Goldman(Executive Officer)Linda Powers(Executive Officer, Director)inLinda F. Powers(Class III Director, Chairperson, President and Chief Executive Officer, Chief Financial and Accounting Officer)in
BoardNavid Malik(Director)
Co-investorsVedanta Capital
OneMedNet provides de-identified, regulatory-grade real-world data (RWD), including longitudinal clinical and imaging patient records, and AI-driven data masking that strips PII and HIPAA-sensitive details.
AI & Machine LearningData & InfrastructureHealthtechEden Prairie, US
Jeffrey Yu(Executive Officer, Director)Aaron Green(Executive Officer, Director)Lisa Embree(Executive Officer)THOMAS HIATT(Director)JERRY HIATT(Executive Officer, Director)CHRISTOPHER HANNA(Executive Officer, Director)
PDS Biotechnology is a clinical-stage company developing immunotherapies for cancer and infectious diseases based on its Versamune platform technology, which uses lipid nanoparticles to activate T cells against tumor antigens, and an interleukin-12 antibody drug conjugate called PDS01ADC designed to enhance immune responses in the tumor microenvironment.
BiotechNorth Brunswick, US
Frank K. Bedu-Addo(Executive Officer)inGregory L. Conn(Chief Scientific Officer)Frank Bedu-Addo(President, Chief Executive Officer, Principal Executive Officer and Director)inKirk Shepard(Chief Medical Officer)inLars Boesgaard(Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer)inStephan Toutain(Chief Operating Officer)in
Co-investorsEMV Capital
Medicus Pharma is a biotech company that identifies, acquires, and advances clinical-stage therapeutic assets through development and commercialization.
BiotechHealthtechToronto, US
Carolyn Bonner(President)inEdward Brennan(Chief Medical Officer)Raza Bokhari(Chairman and Chief Executive Officer)inErica Monaco(Chief Operating Officer)inJames Quinlan(Chief Financial Officer)
BoardRobert J. Ciaruffoli(Director)
Predictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.
Advanced ManufacturingAI & Machine LearningBiotechDeep TechHealthtechMedical DevicesPittsburgh, US
Josh Blacher(Executive Officer)inRaymond Vennare(Executive Officer, Director)inCarl I Schwartz(Executive Officer, Director, Promoter)Bob Myers(Executive Officer)inJoshua Kornberg(Executive Officer, Director)David Johnson(Executive Officer)in
Valo.ai provides tools for Salesforce stakeholders to manage security risks, reduce costs and complexity, and improve administrative efficiency.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaS
Jari Salomaa(Founder)in
Co-investorsInventureSpintop Ventures
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.